Cargando…
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review
Glioblastoma multiforme (GBM) is one of the most frequent and aggressive primary tumors in the central nervous system, representing more than 60% of all brain tumors in adults. Primary GBM remains incurable with a poor prognosis both for limited therapeutic alternatives and for a high risk of progre...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294966/ https://www.ncbi.nlm.nih.gov/pubmed/35949909 http://dx.doi.org/10.1159/000524954 |